AIL
UTHR icon

AGF Investments LLC’s United Therapeutics UTHR Stock Holding History

AGF Investments LLC’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,169
Closed -$901K – 521
2021
Q4 		$901K Buy
4,169
+1,281
+44% +$251K 0.08% 80
2021
Q3 		$533K Sell
2,888
-422
-13% -$83.1K 0.05% 226
2021
Q2 		$594K Sell
3,310
-474
-13% -$90.3K 0.06% 188
2021
Q1 		$633K Sell
3,784
-1,878
-33% -$313K 0.08% 173
2020
Q4 		$859K Sell
5,662
-7,405
-57% -$972K 0.1% 89
2020
Q3 		$1.32M Buy
13,067
+1,326
+11% +$145K 0.15% 133
2020
Q2 		$1.42M Buy
11,741
+4,357
+59% +$490K 0.14% 105
2020
Q1 		$700K Sell
7,384
-1,896
-20% -$180K 0.09% 178
2019
Q4 		$817K Buy
9,280
+3,740
+68% +$329K 0.15% 293
2019
Q3 		$442K Sell
5,540
-14,843
-73% -$1.2M 0.1% 304
2019
Q2 		$1.59M Buy
20,383
+1,499
+8% +$140K 0.33% 89
2019
Q1 		$2.22M Buy
18,884
+3,149
+20% +$367K 0.5% 62
2018
Q4 		$1.71M Buy
15,735
+6,816
+76% +$790K 0.24% 99
2018
Q3 		$1.14M Buy
8,919
+1,103
+14% +$136K 0.14% 146
2018
Q2 		$886K Buy
7,816
+5,333
+215% +$586K 0.1% 177
2018
Q1 		$279K Buy
2,483
+2,442
+5,956% +$310K 0.05% 238
2017
Q4 		$6K Hold
41
– – ﹤0.01% 692
2017
Q3 		$5K Hold
41
– – ﹤0.01% 731
2017
Q2 		$5K Hold
41
– – ﹤0.01% 725
2017
Q1 		$6K Sell
41
-43
-51% -$6.51K ﹤0.01% 733
2016
Q4 		$13K Buy
+84
New +$10.7K ﹤0.01% 449

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

AGF Investments LLC's UTHR Position: Q1 2022 in Review

AGF Investments LLC sold out of United Therapeutics (UTHR) in Q1 2022, closing a stake of 4,169 shares — an estimated $901K sold.

AGF Investments LLC first reported a position in UTHR in Q4 2016 and held it in 21 quarters. The position peaked at $2.22M in Q1 2019. 428 funds tracked by Wall St. Rank hold UTHR as of Q1 2022.

  • AGF Investments LLC reported no remaining United Therapeutics position as of Q1 2022 after selling out during the quarter.
  • AGF Investments LLC sold 4,169 United Therapeutics shares in Q1 2022, an estimated $901K.
  • AGF Investments LLC first reported a position in United Therapeutics in Q4 2016 and held it in 21 quarters.
  • AGF Investments LLC's United Therapeutics position peaked at $2.22M in Q1 2019.
  • 428 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2022.

Based on AGF Investments LLC's 13F filing for Q1 2022, filed 10 May 2022.